BRIEF-Tenaya Therapeutics Announces 2026 Strategic Priorities

Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc.

TNYA

0.00

Jan 9 (Reuters) - Tenaya Therapeutics Inc TNYA.O:

  • TENAYA THERAPEUTICS ANNOUNCES 2026 STRATEGIC PRIORITIES AND ANTICIPATED MILESTONES

  • TENAYA THERAPEUTICS INC - RAISED $60 MILLION IN 4Q25 TO SUPPORT RUNWAY THROUGH MID-2027

  • TENAYA THERAPEUTICS - EXPECTS TO REPORT ONE-YEAR COHORT 1 DATA & EARLY COHORT 2 DATA FROM RIDGE-1 STUDY OF TN-401 FOR PKP2-ASSOCIATED ARVC IN H1 2026

  • TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-201 IN 2026

  • TENAYA THERAPEUTICS INC - PLANS TO PURSUE REGULATORY ALIGNMENT ON TN-401 IN H2 2026

Source text: ID:nGNX5xRRdC

Further company coverage: TNYA.O


((Reuters.Briefs@thomsonreuters.com;))

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.